Navigation Links
Lilly Commences Cash Tender Offer for ImClone Systems at $70 Per Share
Date:10/14/2008
Post Your Comments:
*Name:
*Comment:
*Email:
Other Biology Technology:Rib-X Pharmaceuticals, Inc. Announces Formation of Clinical Advisory Board 2Rib-X Pharmaceuticals, Inc. Announces Formation of Clinical Advisory Board 3OncologySTAT Advisors Name Year's Top Developments in Cancer Treatment and Research 2OncologySTAT Advisors Name Year's Top Developments in Cancer Treatment and Research 3OncologySTAT Advisors Name Year's Top Developments in Cancer Treatment and Research 4Peregrine Pharmaceuticals Reports Financial Results for the First Quarter of Fiscal Year 2009 2Peregrine Pharmaceuticals Reports Financial Results for the First Quarter of Fiscal Year 2009 3Peregrine Pharmaceuticals Reports Financial Results for the First Quarter of Fiscal Year 2009 4Peregrine Pharmaceuticals Reports Financial Results for the First Quarter of Fiscal Year 2009 5Peregrine Pharmaceuticals Reports Financial Results for the First Quarter of Fiscal Year 2009 6Peregrine Pharmaceuticals Reports Financial Results for the First Quarter of Fiscal Year 2009 7Peregrine Pharmaceuticals Reports Financial Results for the First Quarter of Fiscal Year 2009 8Peregrine Pharmaceuticals Reports Financial Results for the First Quarter of Fiscal Year 2009 9Peregrine Pharmaceuticals Reports Financial Results for the First Quarter of Fiscal Year 2009 10